Lin Pei

3.2k total citations
48 papers, 2.6k citations indexed

About

Lin Pei is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Lin Pei has authored 48 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Cancer Research. Recurrent topics in Lin Pei's work include Cancer, Hypoxia, and Metabolism (10 papers), Pituitary Gland Disorders and Treatments (9 papers) and Epigenetics and DNA Methylation (7 papers). Lin Pei is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Pituitary Gland Disorders and Treatments (9 papers) and Epigenetics and DNA Methylation (7 papers). Lin Pei collaborates with scholars based in United States, China and Japan. Lin Pei's co-authors include Шломо Мелмед, B. Scheithauer, Kálmán Kovács, Wenwen Chien, Dara Kallop, Timothy Hoey, Scott Powers, Jinfeng Liu, Mei Jia and Kelly E. Mayo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Lin Pei

46 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin Pei United States	24	1.3k	844	488	478	396	48	2.6k
Leonard Girnita Sweden	36	2.5k 1.9×	1.1k 1.3×	781 1.6×	898 1.9×	216 0.5×	72	3.7k
Prashant Bavi Saudi Arabia	34	1.4k 1.1×	270 0.3×	929 1.9×	699 1.5×	215 0.5×	76	2.8k
Béatrice Parfait France	30	1.5k 1.2×	490 0.6×	295 0.6×	629 1.3×	258 0.7×	83	3.3k
Maria Grazia Borrello Italy	41	2.6k 2.0×	1.6k 1.9×	1.6k 3.2×	741 1.6×	561 1.4×	86	4.9k
Péter Igaz Hungary	29	1.4k 1.1×	611 0.7×	411 0.8×	1.5k 3.2×	262 0.7×	179	2.8k
Gabriella De Vita Italy	26	2.5k 1.9×	393 0.5×	497 1.0×	1.3k 2.8×	209 0.5×	57	3.5k
Haruhiko Kouhara Japan	21	1.6k 1.3×	542 0.6×	232 0.5×	224 0.5×	163 0.4×	49	2.5k
Ashraf Dallol Saudi Arabia	33	2.8k 2.2×	462 0.5×	515 1.1×	1.3k 2.7×	110 0.3×	80	4.1k
Philip Jonsson United States	27	1.4k 1.0×	171 0.2×	773 1.6×	902 1.9×	208 0.5×	41	2.8k
Lisa Happerfield United Kingdom	27	995 0.8×	348 0.4×	656 1.3×	658 1.4×	339 0.9×	43	2.4k

Countries citing papers authored by Lin Pei

Since Specialization

Citations

This map shows the geographic impact of Lin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Pei more than expected).

Fields of papers citing papers by Lin Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Pei. The network helps show where Lin Pei may publish in the future.

Co-authorship network of co-authors of Lin Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Pei. A scholar is included among the top collaborators of Lin Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Pei. Lin Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Li, Yining Li, Aimin Zhang, et al.. (2024). Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer. Clinica Chimica Acta. 561. 119814–119814. 1 indexed citations

Li, Xiaowei, et al.. (2022). Association of Procalcitonin with the Patient’s Infection Characteristics and Prognosis after Hematopoietic Stem Cell Transplantation. Disease Markers. 2022. 1–7.

Song, Junxian, et al.. (2022). Case Report: Familial Pseudohyperkalemia Due to Red Blood Cell Membrane Leak in a Chinese Patient. Frontiers in Medicine. 9. 825174–825174. 2 indexed citations

Han, Yi, Yuanxiao Wang, Lin Pei, et al.. (2022). Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer. Frontiers in Endocrinology. 12. 816748–816748. 7 indexed citations

Cheng, Zhangkai J., et al.. (2021). Dietary Structure and Nutritional Status of Chinese Beekeepers: Demographic Health Survey. JMIR Public Health and Surveillance. 7(5). e28726–e28726. 2 indexed citations

Wang, Yuanxiao, et al.. (2021). The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer. Frontiers in Genetics. 12. 703205–703205. 35 indexed citations

Yang, Liang, Zhaoming Chen, Lin Pei, et al.. (2020). A New Classifier Based on Laboratory Indicators for Early Diagnosis and Prognosis Prediction of Ewing's Sarcoma. Clinical Laboratory. 66(04/2020). 1 indexed citations

Pei, Lin, et al.. (2020). Study on the relationship between FFA and gout flare. Clinical Rheumatology. 39(4). 1251–1255. 5 indexed citations

Pei, Lin, et al.. (2019). Kaempferol Modulates Autophagy and Alleviates Silica-Induced Pulmonary Fibrosis. DNA and Cell Biology. 38(12). 1418–1426. 47 indexed citations

10.

Liu, Lianhua, et al.. (2018). Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer. BioMetals. 31(5). 797–805. 32 indexed citations

11.

Pei, Lin, et al.. (2017). Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer. Medicine. 96(31). e7663–e7663. 56 indexed citations

12.

Stawicki, Scott, Suzana S. Couto, Jeffrey Eastham‐Anderson, et al.. (2010). An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies. Oncogene. 29(38). 5254–5264. 182 indexed citations

13.

Tan, Chalet, J. Zha, Jinfeng Liu, et al.. (2009). Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene. 28(39). 3442–3455. 233 indexed citations

14.

Mu, David, Liyun Chen, Xiping Zhang, et al.. (2003). Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 3(3). 297–302. 208 indexed citations

15.

Pei, Lin, Peng Yue, Ying Yang, et al.. (2002). PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.. PubMed. 62(19). 5420–4. 77 indexed citations

16.

Chien, Wenwen & Lin Pei. (2000). A Novel Binding Factor Facilitates Nuclear Translocation and Transcriptional Activation Function of the Pituitary Tumor-transforming Gene Product. Journal of Biological Chemistry. 275(25). 19422–19427. 97 indexed citations

17.

Greenman, Yona, Paul D. Woolf, John G. Coniglio, et al.. (1996). Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan.. The Journal of Clinical Endocrinology & Metabolism. 81(4). 1628–1633. 34 indexed citations

18.

Pei, Lin & Шломо Мелмед. (1995). Characterization of the rat vasoactive intestinal polypeptide receptor gene 5′ region. Biochemical Journal. 308(3). 719–723. 19 indexed citations

19.

Pei, Lin, Шломо Мелмед, B. Scheithauer, et al.. (1995). Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.. PubMed. 55(8). 1613–6. 159 indexed citations

20.

Pei, Lin, Robin E. Dodson, W E Schoderbek, Richard A. Maurer, & Kelly E. Mayo. (1991). Regulation of the a Inhibin Gene by Cyclic Adenosine 3′,5′-Monophosphate after Transfection into Rat Granulosa Cells. Molecular Endocrinology. 5(4). 521–534. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact